This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Hans-Peter Zobel
Introduction
Hans-Peter Zobel is a notable inventor based in Florsheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicaments in particulate form. His innovative approach has led to advancements that could enhance the efficacy of drug delivery systems.
Latest Patents
Hans-Peter Zobel holds a patent for a medicament in particulate form. This medicament features one or more anionic or partially anionic active substances bound to a carrier material. The carrier material consists of a particulate copolymer or homopolymer of acrylic acid or acrylic acid esters. Additionally, the carrier includes oxygen in the ester group, a branched or unbranched alkyl chain with 2-10 carbon atoms, and --NR.sub.2 where R represents H and lower alkyl chains in any combination. The grain size distribution of the carrier is between 10-1000 nm. This innovative formulation has the potential to improve drug absorption and effectiveness.
Career Highlights
Throughout his career, Hans-Peter Zobel has focused on the intersection of chemistry and medicine. His work has been instrumental in developing new pharmaceutical formulations that address various medical needs. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Hans-Peter Zobel has collaborated with notable colleagues, including Christian Noe and Andreas Zimmer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Hans-Peter Zobel's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future developments in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile